Saturday, July 11, 2026

Drug profile · INN

deferoxamine

deferoxamine is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — deferoxamine
Class
Route
Patents
0
Programs
3
Data quality
0.70

Quick answer

deferoxamine is an FDA-listed pharmaceutical active ingredient.

Key facts

INN deferoxamine

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. DEFEROXAMINE , GALLIUM (68GA) CHLORIDE Phase 2 · Disc Medicine · Pulmonary aspergillosis
  2. NaCl 0 for Subarachnoid hemorrhage Phase 2 · Disc Medicine · Subarachnoid hemorrhage
  3. deferoxamine Phase 2 · Chinese Academy of · Intracerebral Hemorrhage

Frequently asked questions

What is deferoxamine?

deferoxamine is an FDA-listed pharmaceutical active ingredient.